X0306 4 2012-11-26 0 0000070318 TENET HEALTHCARE CORP THC 0001205447 FETTER TREVOR 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 1 1 0 0 CEO and President Common Stock 2550 I By spouse Common Stock 2012-11-26 5 G 0 E 71000 0.00 D 394058 D Common Stock 2012-11-26 4 S 0 89721 28.01 D 304337 D Common Stock 2012-11-26 4 M 0 1375000 4.56 A 1679337 D Common Stock 2012-11-26 4 F 0 644005 27.90 D 1035332 D Common Stock 2012-11-27 4 S 0 20599 28.16 D 1014733 D 2009 Options (Right to Buy) 4.56 2012-11-26 4 M 0 1375000 0.00 D 2019-02-26 Common Stock 1375000 0 D All historical share and stock option exercise price data in this Form 4 have been restated to reflect a one-for-four reverse stock split effective as of October 11, 2012. Gift to charitable organizations of shares owned by reporting person. The reporting person received no consideration for the transfer of the shares. The shares were sold in open market broker transactions. The reporting person continues to exceed the Company's stock ownership guidelines. The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $27.86 to $28.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Represents number of shares withheld by the Company at the direction of the reporting person for the payment of option exercise price and related taxes. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (730,995 shares). The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $27.97 to $28.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. As previously reported, the options were granted on February 26, 2009 and vested ratably on each of the first, second and third anniversaries of the date of grant. /s/ Paul A. Castanon, Attorney-in-Fact for Trevor Fetter 2012-11-28